Deyao Li

Title: Deyao Li: Innovator in Protein Degradation

Introduction

Deyao Li is a prominent inventor based in Quincy, MA (US). He has made significant contributions to the field of biochemistry, particularly in the area of protein degradation. With a total of 2 patents, his work focuses on developing innovative compounds and methods that have the potential to treat various diseases.

Latest Patents

Deyao Li's latest patents include groundbreaking research on compounds, compositions, and methods for protein degradation. One of his patents discloses compounds that target SMARCA2, SMARCA4, or BRM, leading to their degradation. This research is crucial for developing treatments for associated disorders and diseases. Another patent involves small molecule targets for bromo/acetyl proteins, revealing bispecific compounds that target EP300/CBP for degradation. This patent also includes pharmaceutical compositions containing these degraders and methods for using them to treat diseases.

Career Highlights

Deyao Li is affiliated with the Dana-Farber Cancer Institute Inc., where he continues to advance his research in protein degradation. His work is instrumental in the ongoing fight against cancer and other related diseases.

Collaborations

Deyao Li collaborates with notable colleagues, including Jun Qi and Virangika K Wimalasena. Their combined expertise enhances the research efforts at the Dana-Farber Cancer Institute Inc.

Conclusion

Deyao Li's innovative work in the field of protein degradation showcases his commitment to advancing medical science. His patents reflect a dedication to developing effective treatments for serious health conditions.